Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for AstraZeneca
Company Monitoring Page for AstraZeneca
latest headlines for company on cafepharma
Empty AstraZeneca plant sized up by CDMO which may or may not be AGC Biologics
Fierce Pharma
Mon, 02/24/20 - 10:33 am
Tags:
AstraZeneca
,
Colorado
,
Japan
,
AGC Biologics
,
drug manufacturing
,
CDMO
Blockbusters in waiting: drug launches to watch in 2020
Pharmaforum
Mon, 02/17/20 - 11:33 pm
Tags:
drug launches
,
Biohaven
,
rimegepant
,
Novartis
,
ofatumumab
,
Celgene
,
ozanimod
,
Akebia Therapeutics
,
vadadustat
,
Biomarin
,
valrox
,
Gilead Sciences
,
filgotinib
,
Novo Nordisk
,
oral semaglutide
,
inclisiran
,
Immunomedics
,
sacituzumab govitecan
,
AstraZeneca
,
Enhertu
,
Bristol-Myers Squibb
,
liso-cel
AstraZeneca cans cancer pipeline efforts
Fierce Biotech
Fri, 02/14/20 - 10:49 am
Tags:
AstraZeneca
,
earnings
,
R&D
,
cancer
,
oncology
AstraZeneca's Chinese investment bank partner raises $229M for its own new fund — and it's all about the coronavirus
Endpoints
Fri, 02/14/20 - 10:46 am
Tags:
AstraZeneca
,
China
,
coronavirus
,
COVID-19
How a cocktail of existing drugs could regenerate insulin-producing cells in diabetes
Fierce Biotech
Thu, 02/13/20 - 10:44 am
Tags:
diabetes
,
insulin
,
Mt Sinai
,
Novo Nordisk
,
Ozempic
,
Rybelsus
,
Victoza
,
Eli Lilly
,
Trulicity
,
AstraZeneca
,
Bydureon
Easing concerns, FibroGen, AstraZeneca secure FDA date for their anemia drug in broad chronic kidney disease population
Endpoints
Wed, 02/12/20 - 10:50 am
Tags:
FibroGen
,
AstraZeneca
,
FDA
,
anemia
,
chronic kidney disease
,
roxadustat
AZ, Daiichi’s new cancer drug Enhertu gets off to the races with quick U.S. launch
Fierce Pharma
Mon, 02/10/20 - 11:42 pm
Tags:
AstraZeneca
,
Daiichi Sankyo
,
clinical trials
,
FDA
,
Enhertu
,
cancer
,
breast cancer
AstraZeneca expanding again in Australia, pledging $133M investment at Sydney site and adding 250 jobs
Fierce Pharma
Fri, 02/7/20 - 11:58 pm
Tags:
AstraZeneca
,
Australia
,
New Zealand
,
drug manufacturing
,
asthma
,
COPD
Antibody-drug conjugates on the march
Pharmaforum
Thu, 01/30/20 - 10:41 am
Tags:
antibody-drug conjugate
,
AstraZeneca
,
Daiichi Sankyo
,
Enhertu
Big pharma backed away from brain drugs. Is a return in sight?
BioPharma Dive
Wed, 01/29/20 - 11:55 pm
Tags:
Big Pharma
,
Neuroscience
,
AstraZeneca
,
Bristol-Myers Squibb
,
GSK
,
Pfizer
,
Amgen
Allergan Offloads Two Drugs to Secure Approval of Merger With AbbVie
Xconomy
Mon, 01/27/20 - 10:57 am
Tags:
Allergan
,
AbbVie
,
AstraZeneca
,
M&A
,
Nestle
After a brief break, AstraZeneca is back at divesting — handing off hypertension meds for $350M
Endpoints
Mon, 01/27/20 - 10:55 am
Tags:
AstraZeneca
,
hypertension
,
Atnahs Pharma
Breast cancer approval in tow, AstraZeneca, Daiichi armed antibody scores in key gastric cancer study
Endpoints
Mon, 01/27/20 - 10:44 am
Tags:
AstraZeneca
,
breast cancer
,
Daiichi Sankyo
,
trastuzumab deruxtecan
,
gastric cancer
AstraZeneca makes case for use of blood thinner Brilinta in stroke patients
Endpoints
Mon, 01/27/20 - 10:40 am
Tags:
AstraZeneca
,
stroke
,
Brilinta
,
clinical trials
,
bloodthinners
After AstraZeneca, Osbourn Reflects on Roles at CAT & MedImmune
Xconomy
Thu, 01/23/20 - 12:15 pm
Tags:
AstraZeneca
,
MedImmune
AstraZeneca commits to being carbon negative by 2030
Pharmaforum
Wed, 01/22/20 - 10:55 am
Tags:
AstraZeneca
,
climate change
,
carbon emissions
,
environmental concerns
Amid U.K. cutbacks, AstraZeneca plows $520M into manufacturing and R&D in France
Fierce Pharma
Tue, 01/21/20 - 11:38 pm
Tags:
AstraZeneca
,
R&D
,
France
,
Brexit
,
UK
,
drug manufacturing
AstraZeneca’s Combination Treatment for HCC Snags Orphan Drug Designation
BioSpace
Mon, 01/20/20 - 10:16 pm
Tags:
AstraZeneca
,
Imfinzi
,
orphan drugs
,
FDA
,
hepatocellular carcinoma
JPM: With Vascepa's U.S. expansion rolling, Amarin CEO holds off partner offers in EU
Fierce Pharma
Thu, 01/16/20 - 11:06 pm
Tags:
Amarin
,
Vascepa
,
Epanova
,
AstraZeneca
,
Acasti
,
Europe
AZ and Merck, racing against Glaxo, nab Lynparza 'priority' boost in ovarian cancer
Fierce Pharma
Mon, 01/13/20 - 11:49 pm
Tags:
AstraZeneca
,
Merck
,
GSK
,
Lynparza
,
ovarian cancer
,
FDA
,
priority review
,
Zejula
Pages
« first
‹ previous
…
45
46
47
48
49
50
51
52
53
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.